AMERICAN CENTURY COMPANIES INC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Back to AKBA Full portfolio

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$578,223

-$91,517 QoQ

Shares Held

415,988

0.0% QoQ

Ownership

0.150%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $762,972,194 across 32 Drug Manufacturers - Specialty & Generic names. AKBA ranks #27 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	6,072,103	$214,709,562
2	LNTH	Lantheus Holdings, Inc.	1,781,106	$135,096,890
3	ZTS	Zoetis Inc.	834,384	$98,632,532
4	VTRS	Viatris Inc	4,629,065	$62,538,668
5	UTHR	UNITED THERAPEUTICS Corp	69,368	$41,133,836
6	RDY	Dr Reddys Laboratories Ltd	1,661,333	$23,009,462
7	EBS	Emergent BioSolutions Inc.	2,425,722	$20,133,492
8	AMPH	Amphastar Pharmaceuticals, Inc.	1,017,538	$19,933,569

All Filings in AKBA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$578,223	415,988	0.0%	Shares	Defined	2026-05-15
2025-12-31	$669,740	415,988	+19.1%	Shares	Defined	2026-02-13
2025-09-30	$953,534	349,280	+288.4%	Shares	Defined	2025-11-12
2025-06-30	$327,370	89,937	-36.9%	Shares	Defined	2025-08-12
2020-12-31	$398,949	142,482	+312.8%	Shares	Defined	2021-02-12
2020-09-30	$86,625	34,512	+54.6%	Shares	Defined	2020-11-13
2020-06-30	$303,214	22,328	-71.4%	Shares	Defined	2020-08-13
2020-03-31	$590,944	77,961	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.